KB Investment Co

Korea Biomedical Industry Development Institute (KBIC) is a pivotal entity in South Korea's life sciences and biomedical sectors. Established to stimulate innovation and economic growth, KBIC supports a wide range of activities in medical, pharmaceutical, and biological fields, focusing on advanced technologies like AI and regenerative medicine. KBIC operates through various initiatives and partnerships to foster a robust ecosystem for biomedical research and development. Key areas of focus include promoting bio-health exports, enhancing R&D capabilities, and nurturing talent within the bio-health industry. The South Korean government provides substantial funding and regulatory support to boost the global competitiveness of Korean bio-pharma companies. The institute emphasizes international collaboration, participating in global conventions and establishing partnerships with leading research institutions and biopharmaceutical companies worldwide. This approach enhances innovation and facilitates the entry of Korean companies into the global market.